Janssen Prevails In Patent Battle With Mylan Over Generics
By Hailey Konnath · May 23, 2023, 11:08 PM EDT
A New Jersey federal judge has ruled that Mylan cannot pursue a generic version of Janssen's schizophrenia drug Invega Trinza, finding that although the patent for Trinza has expired, Mylan's generic...
To view the full article, register now.